Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material)



Similar documents
EMERGENCY PROCEDURES FOR RADIOACTIVE MATERIAL. 2. Prevent the spread of contamination by covering the spill with absorbent paper.

Spills of Radioactive Materials - Emergency Procedures

Emergencies Involving Radiation

TEMPLE UNIVERSITY ENVIRONMENTAL HEALTH AND RADIATION SAFETY

HAZMAT Employee Training D.O.T. Radioactive Material Shipments #8 (02/12)

Chemotherapy Spill Response:

RADIO PHARMACEUTICAL PROCEDURE PROTOCOL: QUADRAMET

Biosafety Spill Response Guide

HAZMAT Employee Training DOT/ NRC- Radioactive Materials Shipments Compliance with 49CFR and 10CFR 71

Rat Creatine Kinase MB isoenzyme,ck-mb ELISA Kit

HAZMAT Employee Training DOT/ NRC- Radioactive Materials Shipments Compliance with 49CFR and 10CFR 71

Quality Assurance Testing of AtomLab Dose Calibrators

Appendix J IBC Biohazard Spill Management Plan

Training on Standard Operating Procedures for Health Care Waste Management Swaziland 12 May, 2011

Prepared for the Department of Energy Office of Transportation and Emergency Management. 02B p65

Canine creatine kinase MB isoenzyme (CK-MB)ELISA Kit

University of Texas-Pan American Environmental Protection Program Regulated Waste Disposal Revised 2010

THE UNIVERSITY OF NEWCASTLE- SCHOOL of BIOMEDICAL SCIENCES

GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS

HAZMAT Employee Training

IX. EMERGENCY PLANNING

Mouse Creatine Kinase MB isoenzyme (CKMB) ELISA

Biological Safety Program

Inc. Wuhan. Quantity Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4 Standard (liquid) 2

Safe Handling of Cytotoxic Materials

Experiment Notebook Format. Experiment Notebooks will be distributed during the first weeks of the second Quarter.

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:

Infectious Waste Management Plan

HANDLING OF RADIOACTIVE WASTES

INFO-0545 RADIOISOTOPE SAFETY MONITORING FOR RADIOACTIVE CONTAMINATION

GUIDE FOR THE PREPARATION OF RADIOACTIVE MATERIAL APPLICATIONS FOR WELL LOGGING OPERATIONS IN KENTUCKY

Hazardous Drugs Spill Kit

IgM ELISA. For the quantitative determination of IgM in human serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.

BOSTON COLLEGE ENVIRONMENTAL HEALTH AND SAFETY LABORATORY GUIDE FOR RENOVATIONS, REMODELS, MOVES AND TERMINATIONS

Hazardous Precautions. Prepared By: Hazardous Precautions Working Group Updated: March 2014

SPILLS & SPILL KITS. Spills -General Guidelines:

Response to Biological Spills in the Laboratory (Intentional or Accidental)

Biosafety Level 2 (BSL-2) Safety Guidelines

To provide direction for the safe handling, administration and disposal of hazardous drugs.

Standard Operating Procedure for Blood Borne Infectious Disease Control Measures at Calvin College

Rat creatine kinase MM isoenzyme (CK-MM) ELISA Kit

Biosafety Guidelines. 5. Pipetting Mechanical pipetting devices must be available and used. Mouth pipetting is prohibited.

High Dose Radioactive Iodine (I-131) Therapy for Treatment of Thyroid Cancer

File: Spill Response Plan for Hazard Chemicals and Mercury Spills. Orig. Date: 12/01/2005 Review Date: January Review Date: March 2010

Human Free Testosterone(F-TESTO) ELISA Kit

Packing for Transportation

Medications or therapeutic solutions may be injected directly into the bloodstream

Creatine Kinase (CK) Enzymatic Assay Kit Manual Catalog #:

CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES

RADIOACTIVE WASTE MANAGEMENT PLAN

Radium-223 Therapy: Handling & Radiation Safety Issues

LIST OF APPENDICES. PART 1 - MODEL PROCEDURES THAT APPLICANTS MAY USE TO PLAN RADIATION SAFETY PROGRAMS [See Appendix X for imact of Part 20 Revision]

Blood Collection and Processing SOP

SAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy #

Guidelines for the Management of Spillage of Cytotoxic Drugs. No changes have been made as evidence base remains current.

UNIVERSITY OF NORTH FLORIDA BIOMEDICAL WASTE MANAGEMENT PLAN DEVELOPED BY: ENVIRONMENTAL HEALTH, SAFETY, INSURANCE & RISK MANAGEMENT

Decontamination and Waste Management

Mouse IgM ELISA. Cat. No. KT-407 K-ASSAY. For the quantitative determination of IgM in mouse biological samples. For Research Use Only. 1 Rev.

Standard Operating Procedure for Dacarbazine in Animals

Quantifying Bacterial Concentration using a Calibrated Growth Curve

Epinephrine/Norepinephrine ELISA Kit

Clean Water: Supply side potable water, not wastewater. Gray Water/Sewage: Wastewater originating from a drain (sink, toilet, urinal).

Particularly Hazardous Substances (PHS) Standard Operating Procedure (SOP)

MATERIALS LICENSE. In accordance with the letter dated January 15, 2009,

Mouse Keyhole Limpet Hemocyanin antibody(igm) ELISA Kit

Radiation Safety for Nurses

RADIATION CONTROL TECHNIQUE #2 INSTRUCTIONS FOR PREPARATION OF RADIOACTIVE WASTE FOR DISPOSAL

Chemical Spill Response Guideline

CHEMICAL SPILL MANAGEMENT GUIDELINES

Information Useful When Developing/Updating Shipping Papers and Radioactive Material Transportation Procedures

Rat creatine kinase MM isoenzyme (CK-MM) ELISA Kit

Standard Operating Procedure for a Chemical Spill

Mouse krebs von den lungen 6 (KL-6) ELISA

Scott & White Institutional Biosafety Committee Compliance Program Biohazardous Material Spill Clean-Up Procedure Policy #IBC.002

Central Line Blood Draw

Blood Borne Pathogen Exposure Control Plan Checklist

experiment5 Understanding and applying the concept of limiting reagents. Learning how to perform a vacuum filtration.

Application Note. ipix A Gamma imager to support various applications

2.3. The management in each HCF shall be responsible for ensuring good waste management practices in their premises.

OESO Ergonomics Division ERGO(3746) Duke Police Corporate Risk Management

Autoclave Safety. Autoclaves are sterilizers using high pressure and high temperature steam. The potential safety risks for the operators are:

Pesticide Spills. Chapter 26. In This Chapter. Keywords. Accidents. Pesticides Act and Environmental Protection Act

Canine Creatine Kinase MM isoenzyme(ck-mm) ELISA. kit

Cytotoxic and Biotherapies Credentialing Programme Module 6

Administration of Meropenem For Child

Policies. Prep Room Policies

Comparison of Medical and DOE Health Physics Programs. Kevin Lee Radiation Safety Officer Palmetto Health

Safe Operating Procedure

Lead Testing and On Site Calibration for Water Testing Detection Range: 2 100ppb

Introduction BIOMEDICAL WASTE

Annual Biomedical Waste Code Training

Guidance sheet 4: Chemical Spill Management

Cytotoxic Agents Safe Management For Nursing Students. Pat Stalker Clinical Educator, LRCP Feb 2015

THE UNIVERSITY OF NEWCASTLE- DISCIPLINE OF MEDICAL BIOCHEMISTRY. STANDARD OPERATING PROCEDURE PROCEDURE NO: GLP 079 MOD: 1st Issue Page: 1 of 7

Biohazardous Waste and Sharps Disposal

Thrombin Generation Assay

DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK

Transcription:

Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material) Table of Content Receiving a Radioactive Package Constancy Test Daily Survey Weekly Wipes Accuracy Test Linearity Geometric Variation Dose Calibrator TLC Single Strip TLC Double Strip QC on Radio labeled RBCs Minor/Major Spill Information and Reporting

Receiving Of A Radioactive Package 1. Date and time 2. What is the content of the package? 3. Does the content match invoice? (circle one) Yes or No 4. Inspect the package on arrive. a. Is there damage? (circle one) Yes or No b. If yes, describe the damage. Was the RSO contacted? c. What is the package s label (circle one) White I, Yellow II, Yellow III) d. Survey @ surface = mr/hr e. Survey @ 1 meter = mr/hr 5. Complete 100 cm 2 wipe test of the package a. Results in cpm = b. What is the well counter efficiency? c. Results in dpm = 6. Monitor the empty package to assure that there is no radioactive contamination Removable contamination should not exceed 0.001 uci or 2200 dpm/cm 2

Nuclear Medicine Program - VCU Constancy Log Use 137 Cc Date 137 Cs 99m Tc 111 In 123 I Pass Y/N Name TA MA %SD TA MA %SD TA MA %SD TA MA %SD Sealed Source Calibration Date of 137 Calibration Date Cs Serial # df 137 Cs for 1 month = 0.99808 TA Theoretical Activity MA Measured Activity

DAILY AMBIENT RADIATION EXPOSURE RATE SURVEY All Dose Rates Are in mr/hr The Month and Year : Survey instrument: Locatio n Date 1 2 3 4 5 6 7 8 9 Comments SC Y/N Initials See department schematic to determine the corresponding numerical locations. SC - Source Check

Weekly Wipe Test Department of Radiation Science Nuclear Medicine Hot Lab Well Counter Efficiency Technologist Date Location WIPE CPM BKG CPM NET CPM DPM 1 2 3 4 5 6 7 8 9 See department schematic to determine the corresponding numerical locations. Weekly Wipe Test Department of Radiation Science Nuclear Medicine Hot Lab Well Counter Efficiency Technologist Date Location WIPE CPM BKG CPM NET CPM DPM 1 2 3 4 5 6 7 8 9 See department schematic to determine the corresponding numerical locations.

Dose Calibrator Accuracy Test Using a low, medium, and high energy sealed source (repeat these steps for each source) determine dose calibrator accuracy. Suggest 57 Co, 137 Cs, and 60 Co 1. Select the appropriate dose calibrator setting and first measure record the background. 2. Now place the corresponding sealed source with the dose calibrator. 3. Assay the source x3 and record each reading. 4. Average the three reading. 5. Subtract the background. 6. Calculate the percent variation based on theoretical and measured levels of activity. 7. Record all your data. Atomic Lab 100 Plus Date Serial # 1781022, 1782007 Name Accuracy Test Sealed Source 1 Radionuclide Reading 1 Background Serial Number Reading 2 Average Activity Theoretical Activity Reading 3 Net Activity Theoretical Measured x 100 Theoretical % Variation Accuracy Test - Sealed Source 2 Radionuclide Reading 1 Background Serial Number Reading 2 Average Activity Theoretical Activity Reading 3 Net Activity Theoretical Measured x 100 % Variation Theoretical Accuracy Test - Sealed Source 3 Radionuclide Reading 1 Background Serial Number Reading 2 Average Activity Theoretical Activity Reading 3 Net Activity Theoretical Measured x 100 Theoretical % Variation What is the level of acceptable variation? Is the accuracy test acceptable? +

Geometry Variation Dose Calibrator Date Time the procedure was Started Ended Volume in ml Measured Activity Expected Activity Percent Error 0.5 1.0 1.5 2.0 2.5 3.0 Draw up between 1 10 mci of 99m Tc into a three ml syringe and expand to 0.5 ml. Measure and record each reading as quickly as possible. Background should not be an issue since that was measured with the morning QC. DC automatically subtracts it to give you net activity. Continue to expand you activity by 0.5mL intervals, measure it to the point where 3.0 ml is recorded. Activity levels should vary less than 10%. Greater amounts require a the determination of the correction factor. Determine the difference between the measured and expected levels of activity for each volume and chart your answer above. Calculate % Error(s) for each Questions 1. Is the variation acceptable? 2. If no, then what is/are the correction factors and where should it be applied?

Linearity Log Date/Time Measured Activity Theoretical Activity Difference in % Plot the Linearity Curve

Kit Compounding and QC One Strips Show your calculations Name of the Clinical Affiliate Name of the pharmaceutical Amount of 99m Tc added to the kit mci. Solution is ml. Amount of saline used to expand the kit ml. Kit concentration is mci/ml? How did you make the kit (ingredients, mixing, heating, sonic bath, incubation time?) What color is the compounded solution? Actual measured amount of activity placed into the vial? mci What is the patient s prescribed dose? mci? How many ml are needed from the vial? ml What was the dose measured in the dose calibrator? mci? (Calculate data below) Using One TLC Strip Write in the values and calculate the percentage.

Kit Compounding and QC Two Strips Show your calculations Name of the Clinical Affiliate Name of the pharmaceutical Amount of 99m Tc added to the kit mci. Solution is ml. Amount of saline used to expand the kit ml. Kit concentration is mci/ml? How did you make the kit (ingredients, mixing, heating, sonic bath, incubation time?) What color is the compounded solution? Actual measured amount of activity placed into the vial? mci What is the patient s prescribed dose? mci? How many ml are needed from the vial? ml What was the dose measured in the dose calibrator? mci? (Calculate data below) Using Two TLC Write in the values and calculate the percentages.

Kit Compounding and QC of Labeled RBCs Show your calculations Name of the Clinical Affiliate Labeling Process 1. Take a 5 ml syringe and wet it with heparin. Then remove 3 ml of patient s whole blood and place this into a reaction vial. 2. Mix gently the contents within the reaction vial and the whole blood and let stand for 5 minutes. 3. To the reaction vial add syringe 1 (sodium hypochlorite), invert 4-5 times, then add contents from syringe 2 (citric acid, sodium citrate, and dextrose) and invert vial another 4-5 times. 4. Add 10 100 mci of 99m TcO 4 - in no greater than a 3 ml solution into the reaction vial and invert 4-5 times. Now let the reaction vial stand for 20 minutes before injecting the dose into the patient. How much activity did you add to the reaction vial in how many ml? mci and ml 5. What was the measured dose to the patient? mci QC the Bound RBCs 1. Remove 0.2 ml of RBC from reaction vial and place into test tube. 2. Add 2.0 ml of saline and gently mix the solutions before centrifuging for 5 minutes. Make use the centrifuge is balanced with an equal amount of liquid at the opposite end. In practice, usually a second tubes of RBCs are used, in case someone messes up the pipetting of plasma. 3. Remove supernatant and place into separate test tube. 4. Measure supernatant (A) in dose calibrator and measure packed cells (B) in the dose calibrator. 5. Calculate the Radiochemical purity of the tagged cells

SPILL/CONTAMINATION PROCEDURES FOR LOW AND HIGH DOSE UNSEALED SOURCES MINOR SPILLS OF LIQUIDS AND SOLIDS 1. NOTIFY: Notify persons in the area that a spill has occurred. 2. PREVENT THE SPREAD OF CONTAMINATION: Cover the spill with absorbent paper. 3. ABSORB LIQUID: Wear gloves and protective clothing such as a lab coat and booties, and clean up the spill using absorbent paper. Carefully fold the absorbent paper with the clean side out and place in a bag labeled caution radioactive material for transfer to a radioactive waste container. All contaminated gloves and any other contaminated disposable material should be placed in the bag. 4. SURVEY: With a G.M. survey meter, check for removable contamination to ensure contamination levels are below trigger levels. Check the area around the spill. Also, check hands, clothing, and shoes of self and anyone else who may be potentially contaminated. 5. DECONTAMINATE: Clean the area with a soap solution. Perform a swipe survey to check for removable contamination. Continue decontamination efforts until swipe surveys show less than the trigger level. 6. REPORT: Report the incident to the Radiation Safety Section and Nuclear Medicine Manager. Complete Spill/Contamination Incident Report and deliver to Nuclear Medicine Manager. MAJOR SPILLS OF LIQUIDS AND SOLIDS 1. CLEAR THE AREA: Notify all persons not involved in the spill to vacate the room. 2. PREVENT THE SPREAD OF CONTAMINATION: Cover the spill with absorbent pads labeled caution radioactive material, but do not attempt to clean it up. To prevent the spread of contamination, clearly indicate the boundaries of the spill and limit the movement of all personnel who may be contaminated. 3. SHIELD THE SOURCE: If possible, the spill should be shielded, but only if it can be done without further contamination or significant increase in radiation exposure. 4. CLOSE THE ROOM: Close the room and lock or otherwise secure the area to prevent entry. 5. CALL FOR HELP: Notify the Radiation Safety Section immediately. Notify Nuclear Medicine Manager immediately. Complete Spill/Contamination Incident Report and deliver to Nuclear Medicine Manager (following personnel decontamination procedure). 6. PERSONNEL DECONTAMINATION: Remove contaminated clothing and flush contaminated skin with lukewarm water and then wash with mild soap. If contamination remains, induce perspiration by covering the area with plastic. Then wash the affected area again to remove any contamination that was released by the perspiration. RADIATION SAFETY SECTION: 828-9131 NUCLEAR MEDICINE MANAGER: 828-4176

GUIDELINES FOR DETERMINING MINOR SPILL VS. MAJOR SPILL Estimate the amount of radioactivity spilled. Institute a major or minor spill/contamination procedure based on the table below. Spills/contamination above the millicurie trigger level are considered major. Spills below the millicurie trigger level are considered minor. Downgrade to minor spill following decay or restrict access pending complete decay. Radionuclide Diagnostic Trigger Level Table Millicurie Trigger Level Minor Spill if Under/ Major Spill if over mci Trigger Levels Restricted area DPM Trigger Level Unrestricted Area DPM F-18 100 20,000 2,000 Ga-67 10 20,000 2,000 I-123 10 2,000 2,000 In-111 10 2,000 2,000 Tc-99m 100 20,000 2,000 Tl-201 100 20,000 2,000 Therapeutic I-131 1 2,000 200 P-32 1 2,000 2,000 Sm-153 1 2,000 2,000 Sr-89 1 2,000 2,000 Y-90 1 2,000 2,000

NUCLEAR MEDICINE RADIOACTIVE MATERIAL SPILL/CONTAMINATION INCIDENT REPORT Technologist involved in spill: Date: Approximate millicurie amount of spill: Location of spill room: Isotope: Major or Minor Spill (circle one) Description of Incident: Notification: Pre-Clean Post-Clean Personnel Contaminated Contaminated mr/hr DPM Time mr/hr DPM Time Yes No Yes No Yes No Yes No Yes No Survey and Contamination Control: Pre Clean Post Clean Area/Items Contaminated mr/hr DPM Time mr/hr DPM Time Decontaminate: Contacted Radiation Safety YES NO If no why? Who did you speak to? Date: Time: What instructions were you given? (page 1 of 2)

Proceed with decontamination. Wait for Radiation Safety for decontamination supervision. Other: Incident Reported to: Nuclear Medicine Faculty or Staff (required): Radiation Safety (required): : Other Follow up actions: Student Completing Report: Date: Faculty Reviewing Report: Date: Department Chair Reviewing Report: Date: Additional Comments? (page 2 of 2)

Map Room 2133 Nuclear Medicine Hot Lab